Dear Reader,
This issue of Human Vaccines & Immunotherapeutics features four research articles and one review on Influenza: an analysis of high-dose vaccine usage in the U.S. (McGrath, p 537), assessment of vaccine effectiveness in young children under conditions of co-infection with RSV (Nakata, p 545), review of immunogenicity of an intramuscular vaccine in the elderly (Camilloni, p 553), analysis of cost-effectiveness of quadrivalent vaccine in Hong Kong (You, p 564), and a preclinical study of a novel immunization method (Crevar, p 572).
In the section on Novel Vaccines, we are pleased to introduce a two-part review on gastroenteritis vaccines (O’Ryan, p 584, and O’Ryan, p 601), an early clinical trial of a 4-component S. aureus vaccine (Levy, p 620), a phase 3 trial of S. aureus vaccine for adults on hemodialysis (Fattom, p. 632), a preclinical study of a Rickettsia vaccine (Gong, p 642), a review on biodegradable polymeric microsphere-based vaccines (Lin, p 650), and a short report on the use of proteo-liposomes in tuberculosis protection (Tirado, p 657).
The section Licensed Vaccines brings a research report on varicella mortality in the U.S. (Leung, p 662), a review of mathematical models of pertussis epidemiology (Campbell, p 669), and a Letter on a very rare fatality caused by the varicella vaccine strain (Woo, p 679).
Three Immunotherapy papers include a case report on bevacizumab treatment of hereditary haemorrhagic telangiectasia (Kochanowski, p 680), analysis of the DC-based technology landscape (Kong, p 682) and a commentary on the design of universal cancer vaccines (Lokhov, p 689).
We are presenting a phase 3 study of 23-valent Pneumococcal vaccine in healthy Chinese subjects (Li, p 699), four articles on Vaccine Acceptance: analysis of vaccine uptake in health-care workers (Tuckerman, p 704), maternal pertussis vaccination among New York obstetric providers (Bonville, p 713), herpes -zoster vaccination in South Korea (Yang, p 719), and influenza vaccination among university staff (Amour, p 727), followed by a clinical study of an additional booster dose in HPV vaccine (Gilca, p 732),
The Technology section contains reports on microarray analysis of post-vaccination gene expression (Zhang, p 739), electroporation-based intradermal DNA vaccine delivery (McCoy, p 746), and a commentary about CpG mucosal adjuvants (Iho, p 755).
We introduce an analysis of vaccination in Chinese migrant children (Hu, p 761), report on decline in disease after Rotavirus vaccination in Spain (Redondo Gonzalez, p 769), the use of Meningococcal protein PorA as adjuvant (Vasquez, p 776), a commentary on patent eligibility (Chang, p 789), and in silico design of HIV vaccine (Yang, p 795).
In our monthly News, Policy and Profiles (NP&P) track, we offer a selection of the latest news in the field of vaccines and immunotherapeutics. In this section, we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam C Weiss
Acquisitions Editor